On the basis of age at the initial diagnosis, the International Neuroblastoma Pathology Classification (INPC), INSS and N-MYC amplification status, and the Chinese Children’s Cancer Group (CCCG) developed a risk-stratification system and classified NB into three categories: low risk (LR), intermediate risk (IR), and high risk (HR). This evidence concerns the gene MYC and neuroblastoma.